Home Pilots Seer Medical receives FDA 510(k) for its at-home epilepsy diagnosis aide Pilots Seer Medical receives FDA 510(k) for its at-home epilepsy diagnosis aide By - September 26, 2022 30 0 Facebook Twitter Pinterest WhatsApp The company’s Seer Home device allows for potential epilepsy diagnosis through at-home data collection. RELATED ARTICLESMORE FROM AUTHOR Pilots Medtronic issues voluntary recall of MiniMed insulin pumps Pilots Hybrid primary care company Rezilient Health scores $10M Pilots Empathy Health Technologies raises $2.8M for Sober Sidekick app LEAVE A REPLY Cancel reply Please enter your comment! Please enter your name here You have entered an incorrect email address! Please enter your email address here Save my name, email, and website in this browser for the next time I comment. FOLLOW ME0FansLike0FollowersFollow0SubscribersSubscribe POPULAR ARTICLES Q&A: Using 3D printing to analyze MS lesions Pilots - November 14, 2022 0 AMA survey: Doctors more optimistic about digital health tools Pilots - September 14, 2022 0 Q&A: How Soda Health plans to change ‘patchwork’ supplemental benefits Pilots - October 7, 2022 0 UpStream raises $140M to scale value-based primary care support services Pilots - December 1, 2022 0 Southeast Asian online pharmacy platform SwipeRx bags $27M in Series B funding Pilots - May 24, 2022 0 POPULAR CATEGORIESPilots2166Applications682Testing237Collaborations15GitHub3